End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
165,300.00 KRW | +0.30% |
|
-1.67% | +43.99% |
May. 21 | Samsung BioLogics spin-off to separate contract drug making, new growth drivers | RE |
May. 01 | Samsung C&T's Net Attributable Income Inches Higher in Q1 | MT |
Capitalization | 26,985B 19.59B 17.05B 16B 14.57B 26.85B 1,701B 30.25B 189B 72.81B 777B 73.53B 71.97B 2,856B | P/E ratio 2025 * |
11.7x | P/E ratio 2026 * | 10.5x |
---|---|---|---|---|---|
Enterprise value | 25.56B 18.56M 16.15M 15.16M 13.8M 25.43M 1.61B 28.65M 179M 68.96M 736M 69.65M 68.17M 2.7B | EV / Sales 2025 * |
0.6x | EV / Sales 2026 * | 0.56x |
Free-Float |
47.13% | Yield 2025 * |
1.63% | Yield 2026 * | 1.76% |
More valuation ratios
* Estimated data
More news
Samsung C&T : Q1 2024 earnings | 24-04-24 | PU |
Samsung C&T : Letter to Shareholders | 24-03-14 | PU |
Samsung chief acquitted in controversial 2015 merger case | 24-02-05 | AQ |
Samsung C&T : 3Q Interim Financial Statements | 24-01-02 | PU |
Samsung C&T : 3QEarnings Release | 23-10-25 | PU |
More news
1 day | +0.30% | ||
1 week | -4.56% | ||
Current month | +10.35% | ||
1 month | +33.41% | ||
3 months | +35.16% | ||
6 months | +39.02% | ||
Current year | +43.99% |
1 week | 162,500 | ![]() | 173,300 |
1 month | 122,000 | ![]() | 174,500 |
Current year | 108,100 | ![]() | 174,500 |
1 year | 108,100 | ![]() | 174,500 |
3 years | 99,300 | ![]() | 174,500 |
5 years | 99,300 | ![]() | 174,500 |
10 years | 73,500 | ![]() | 203,000 |
Manager | Title | Age | Since |
---|---|---|---|
Jae-Eon Lee
CEO | Chief Executive Officer | 57 | 2024-03-14 |
Hai-Lin Jeong
CEO | Chief Executive Officer | 61 | 2023-03-16 |
Se-Chul Oh
CEO | Chief Executive Officer | 63 | 2021-03-18 |
Director | Title | Age | Since |
---|---|---|---|
Janice Lee
BRD | Director/Board Member | 64 | 2023-03-16 |
Sang-Seung Lee
BRD | Director/Board Member | 62 | 2023-03-16 |
Joong-Kyung Choi
BRD | Director/Board Member | 69 | 2024-03-14 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0.27% | 17 M€ | +1.56% | - | |
0.2% | 26 M€ | +13.37% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.30% | -4.56% | +25.80% | +46.93% | 19.64B | ||
-0.89% | -0.83% | -6.73% | +93.64% | 74.9B | ||
-1.05% | +0.64% | +3.53% | +105.58% | 74.38B | ||
-1.69% | +0.14% | -20.32% | +84.50% | 59.56B | ||
-1.59% | -6.27% | -26.87% | +15.42% | 32.83B | ||
-1.12% | +1.53% | -2.62% | +119.48% | 33.6B | ||
-0.68% | +0.80% | -5.40% | +98.80% | 30.71B | ||
+0.71% | +3.78% | +6.40% | +104.35% | 22.69B | ||
+1.35% | -2.68% | -24.88% | -12.95% | 9.75B | ||
-1.45% | -2.97% | +18.71% | +122.43% | 8.95B | ||
Average | -0.61% | +0.02% | -3.24% | +77.82% | 36.7B | |
Weighted average by Cap. | -0.91% | +0.63% | -5.48% | +86.41% |
2025 * | 2026 * | |
---|---|---|
Net sales | 42,412B 30.79B 26.8B 25.15B 22.9B 42.2B 2,673B 47.54B 297B 114B 1,221B 116B 113B 4,488B | 44,934B 32.62B 28.4B 26.65B 24.26B 44.71B 2,832B 50.37B 315B 121B 1,294B 122B 120B 4,755B |
Net income | 2,456B 1.78B 1.55B 1.46B 1.33B 2.44B 155B 2.75B 17.19B 6.63B 70.72B 6.69B 6.55B 260B | 2,644B 1.92B 1.67B 1.57B 1.43B 2.63B 167B 2.96B 18.51B 7.13B 76.14B 7.21B 7.05B 280B |
Net Debt | -1,425B -1.03B -901M -845M -770M -1.42B -89.85B -1.6B -9.98B -3.85B -41.05B -3.88B -3.8B -151B | -1,869B -1.36B -1.18B -1.11B -1.01B -1.86B -118B -2.09B -13.08B -5.04B -53.81B -5.09B -4.98B -198B |
More financial data
* Estimated data
Employees
7,907
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-06-19 | 165,300.00 ₩ | +0.30% | 421,152 |
25-06-18 | 164,800.00 ₩ | -4.41% | 915,121 |
25-06-17 | 172,400.00 ₩ | +0.12% | 549,321 |
25-06-16 | 172,200.00 ₩ | +3.80% | 619,409 |
25-06-13 | 165,900.00 ₩ | -1.31% | 647,645 |
End-of-day quote Korea S.E., June 18, 2025
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
15
Last Close Price
165,300.00KRW
Average target price
183,066.67KRW
Spread / Average Target
+10.75%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A028260 Stock
Select your edition
All financial news and data tailored to specific country editions